DJIA 16,528.03 -114.98 -0.69%
NASDAQ 4,776.51 -51.82 -1.07%
S&P 500 1,972.18 -16.69 -0.84%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

10.77 -0.85 (-7.31%)

REAL-TIME: Last trade at

Extended Hours: $10.14 -$0.63 (-5.85%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

NVAX $10.77 -7.31%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.49
Previous Close $11.62
Daily Range $10.74 - $11.70
52-Week Range $3.92 - $15.01
Market Cap $2.9B
P/E Ratio -29.05
Dividend (Yield) $0.00 (0.0%)
Volume 4,217,932
Average Daily Volume 5,406,377
Current FY EPS -$0.40

Sector

Healthcare

Industry

Drug Makers

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website: http://www.novavax.com/

News & Commentary

Can Novavax Inc.'s Stock Inoculate Your Portfolio From More Market Mayhem?

This small-cap clinical-stage biopharma company is on a stellar run this year. Can it continue?

Benzinga's Top #PreMarket Losers

Interesting NVAX Put And Call Options For April 2016

Novavax to Host 3rd Annual Analyst and Investor Meeting on Tuesday, September 29, 2015 from 9:00 a.m

Novavax to Host 3rd Annual Analyst and Investor Meeting on Tuesday, September 29, 2015 from 9:00 a.m. - 11:00 a.m. ET

4 Biotechs Piper Jaffray Is Buying On The Pullback

How I made money when the Dow lost 1,000 points

I made money when the Dow lost 1,000 points

Jim Cramer's Top Takeaways: Novavax, Cisco, Freshpet, Macy's

Novavax Breathing Easier With Positive RSV Data

Novavax (NVAX) Shows Strength: Stock Moves Up 24.1%

Novavax (NVAX) In A Perilous Reversal

See More NVAX News...

NVAX's Top Competitors

NVAX $10.77 (-7.31%)
Current stock: NVAX
AMGN $151.78 (-2.64%)
Current stock: AMGN
GILD $105.07 (-2.51%)
Current stock: GILD
BIIB $297.30 (-2.10%)
Current stock: BIIB